PETER LIN to Cardiovascular Diseases
This is a "connection" page, showing publications PETER LIN has written about Cardiovascular Diseases.
Connection Strength
0.253
-
Treatment Inertia in Patients With Familial Hypercholesterolemia. J Am Heart Assoc. 2021 07 20; 10(14):e020126.
Score: 0.076
-
miRNAs: roles and clinical applications in vascular disease. Expert Rev Mol Diagn. 2011 Jan; 11(1):79-89.
Score: 0.037
-
Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy. Am J Cardiol. 2008 Nov 01; 102(9):1142-5.
Score: 0.031
-
Development of small-diameter vascular grafts. World J Surg. 2007 Apr; 31(4):682-9.
Score: 0.028
-
Lymphotoxin-alpha and cardiovascular disease: clinical association and pathogenic mechanisms. Med Sci Monit. 2006 Jul; 12(7):RA121-4.
Score: 0.027
-
Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease. Med Sci Monit. 2004 Aug; 10(8):RA187-92.
Score: 0.023
-
Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular diseases. Cardiovasc Drug Rev. 2004; 22(4):309-19.
Score: 0.022
-
Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med Sci Monit. 2010 May; 16(5):RA93-100.
Score: 0.009